[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Lucien Wolfe [@LucienWolfe111](/creator/twitter/LucienWolfe111) on x 15.9K followers Created: 2025-07-17 14:36:24 UTC You ever notice how every “discounted drug” victory gets broadcast like a campaign ad… but no one talks about the timing? This price drop for Eliquis wasn’t magic. It came after Pfizer’s execs had private closed-door meetings with two PACs that just pivoted funding to MAGA candidates. You won’t find that on Fox or CNN. I tried. And here’s the part nobody brings up: Eliquis is co-marketed by Bristol-Myers Squibb, a company that’s been lobbying for looser direct-to-consumer drug laws since 2022. They needed a win. So now they slash prices (just for one pill), get a PR boost, and in return? No Medicare price negotiation. No patent reform. No mention of the XX other drugs that went up in price last quarter. Funny how it always plays out this way. Right before campaign season. Try finding that in the mainstream writeups. Is this really about helping patients, or building a narrative? XXXXX engagements  **Related Topics** [maga](/topic/maga) [$pacs](/topic/$pacs) [Post Link](https://x.com/LucienWolfe111/status/1945855109004763195)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Lucien Wolfe @LucienWolfe111 on x 15.9K followers
Created: 2025-07-17 14:36:24 UTC
You ever notice how every “discounted drug” victory gets broadcast like a campaign ad… but no one talks about the timing?
This price drop for Eliquis wasn’t magic. It came after Pfizer’s execs had private closed-door meetings with two PACs that just pivoted funding to MAGA candidates. You won’t find that on Fox or CNN. I tried.
And here’s the part nobody brings up: Eliquis is co-marketed by Bristol-Myers Squibb, a company that’s been lobbying for looser direct-to-consumer drug laws since 2022. They needed a win.
So now they slash prices (just for one pill), get a PR boost, and in return? No Medicare price negotiation. No patent reform. No mention of the XX other drugs that went up in price last quarter.
Funny how it always plays out this way. Right before campaign season.
Try finding that in the mainstream writeups. Is this really about helping patients, or building a narrative?
XXXXX engagements
